ALPINE IMMUNE SCIENCES, INC. financial data

Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 09 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 581% % 65%
Debt-to-equity 26% % -62%
Return On Assets -12% % 51%
Operating Margin -91% % 65%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 65,560,484 shares 37%
Common Stock, Shares, Outstanding 65,552,322 shares 37%
Weighted Average Number of Shares Outstanding, Basic 64,033,018 shares 35%
Weighted Average Number of Shares Outstanding, Diluted 64,033,018 shares 35%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $56,521,000 USD 119%
Research and Development Expense $83,780,000 USD 14%
General and Administrative Expense $24,095,000 USD 30%
Operating Income (Loss) $51,354,000 USD 23%
Net Income (Loss) Attributable to Parent $36,836,000 USD 42%
Earnings Per Share, Basic -1 USD/shares 64%
Earnings Per Share, Diluted -1 USD/shares 64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $33,015,000 USD 128%
Accounts Receivable, after Allowance for Credit Loss, Current $42,000 USD -94%
Assets, Current $308,251,000 USD 55%
Property, Plant and Equipment, Net $1,356,000 USD -20%
Operating Lease, Right-of-Use Asset $7,317,000 USD -9.1%
Assets $373,646,000 USD 43%
Accounts Payable, Current $4,170,000 USD 151%
Accrued Liabilities, Current $16,891,000 USD 40%
Contract with Customer, Liability, Current $10,227,000 USD -75%
Liabilities, Current $32,238,000 USD -44%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $8,705,000 USD -11%
Liabilities $40,943,000 USD -56%
Accumulated Other Comprehensive Income (Loss), Net of Tax $263,000 USD 35%
Retained Earnings (Accumulated Deficit) $274,063,000 USD -16%
Stockholders' Equity Attributable to Parent $332,703,000 USD 96%
Liabilities and Equity $373,646,000 USD 43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $27,690,000 USD -5.9%
Net Cash Provided by (Used in) Financing Activities $19,351,000 USD
Net Cash Provided by (Used in) Investing Activities $2,562,000 USD -109%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 65,552,322 shares 34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,905,000 USD -1101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33,284,000 USD 126%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Depreciation $147,000 USD 5%
Payments to Acquire Property, Plant, and Equipment $19,000 USD -80%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $36,692,000 USD 42%
Operating Lease, Liability, Current $950,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) $0 USD
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $12,067,000 USD 22%
Interest Expense $28,000 USD -93%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%